| 14th Oct 2025 7:00 am |
RNS |
Inaphaea Commercial update |
| 29th Sep 2025 7:00 am |
RNS |
Half-year Report |
| 18th Sep 2025 7:00 am |
RNS |
Inaphaea Commercial Update |
| 1st Sep 2025 7:00 am |
RNS |
Cytolytix Commercial update |
| 26th Aug 2025 7:00 am |
RNS |
Commercial update |
| 7th Aug 2025 10:51 am |
RNS |
ValiRx Awarded Grant from Open University |
| 5th Aug 2025 9:53 am |
RNS |
Update on Evaluation Agreement with Stingray Bio |
| 4th Aug 2025 7:00 am |
RNS |
Licensing Agreement with Dominion Biotech Ltd |
| 29th Jul 2025 7:00 am |
RNS |
Collaboration Agreement with Voxcell BioInnovation |
| 30th Jun 2025 3:48 pm |
RNS |
Result of AGM |
| 20th Jun 2025 7:00 am |
RNS |
Ambrose Exercise Option on VAL401 |
| 9th Jun 2025 10:57 am |
RNS |
ValiRx Investor Webinar |
| 6th Jun 2025 10:54 am |
RNS |
Holding(s) in Company |
| 6th Jun 2025 7:00 am |
RNS |
Final Results & Notice of AGM |
| 3rd Jun 2025 7:00 am |
RNS |
New Evaluation and Material Transfer Agreement |
| 20th May 2025 1:25 pm |
RNS |
Holding(s) in Company |
| 12th May 2025 7:00 am |
RNS |
Inaphaea Deal Extension With Dominion |
| 30th Apr 2025 7:00 am |
RNS |
Commercial Update |
| 3rd Apr 2025 7:00 am |
RNS |
Termination of Letter of Intent with TheoremRx |
| 27th Mar 2025 7:00 am |
RNS |
Directorate Changes and new Advisory Board |
| 21st Mar 2025 11:07 am |
RNS |
Director Disclosure Update |
| 24th Feb 2025 7:00 am |
RNS |
Conclusion of Evaluation Project |
| 3rd Feb 2025 7:00 am |
RNS |
Inaphaea Evaluation and Commercial Use Agreement |
| 30th Jan 2025 7:00 am |
RNS |
Extension of Evaluation Agreement |
| 29th Jan 2025 7:00 am |
RNS |
New Evaluation and Option Agreement |
| 15th Jan 2025 12:47 pm |
RNS |
Holding(s) in Company |
| 15th Jan 2025 11:29 am |
RNS |
Holding(s) in Company |
| 14th Jan 2025 7:00 am |
RNS |
Holding(s) in Company |
| 9th Jan 2025 11:37 am |
RNS |
Holding(s) in Company |
| 9th Jan 2025 11:14 am |
RNS |
Holding(s) in Company |
| 8th Jan 2025 7:00 am |
RNS |
Holding(s) in Company |
| 2nd Jan 2025 11:45 am |
RNS |
Holding(s) in Company |
| 31st Dec 2024 1:06 pm |
RNS |
Holding(s) in Company |
| 31st Dec 2024 8:39 am |
RNS |
Update on proposed sub-license of VAL201 |
| 30th Dec 2024 1:30 pm |
RNS |
Result of GM, Issue of Equity, Warrants and TVR |
| 20th Dec 2024 7:00 am |
RNS-R |
ValiRx launches new interactive investor website |
| 10th Dec 2024 4:45 pm |
RNS |
Broker Offer Results & Director/PDMR Subscription |
| 10th Dec 2024 3:03 pm |
RNS |
Posting of Circular and Notice of General Meeting |
| 9th Dec 2024 7:00 am |
RNS |
Conditional Fundraising & Launch of Broker Offer |
| 22nd Nov 2024 7:00 am |
RNS |
Inaphaea award of HEIF Funding and PhD sponsorship |
